Interpretation Of SPECT/CT Myocardial Perfusion Images: Common Artifacts And Quality Control Techniques

Radiographics

Volumn 31, Issue 7, 2011, Pages 2041-2057

  Dvorak, Ryan A ^a   Brown, Richard K J ^a   Corbett, James R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFACT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; HUMAN; IMAGE ENHANCEMENT; IMAGE SUBTRACTION; METHODOLOGY; MYOCARDIAL PERFUSION IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ARTIFACTS; CORONARY ARTERY DISEASE; HUMANS; IMAGE ENHANCEMENT; MYOCARDIAL PERFUSION IMAGING; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 81255136536     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.317115090     Document Type: Article

References (26)

1. Chang SM, Nabi F, Xu J, Raza U, Mahmarian JJ. Normal stress-only versus standard stress/rest myocar-dial perfusion imaging: similar patient mortality with reduced radiation exposure. J Am Coll Cardiol 2010; 55(3):221-230.
2. Duvall WL, Wijetunga MN, Klein TM, et al. The prognosis of a normal stress-only Tc-99m myocardial perfusion imaging study. J Nucl Cardiol 2010;17(3): 370-377.
3. Lieu HD, Shryock JC, von Mering GO, et al. Regad-enoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood fow velocity in humans. J Nucl Cardiol 2007;14(4): 514-520.
4. Gao Z, Li Z, Baker SP, et al. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affnity and duration of action of A2A agonists. J Pharmacol Exp Ther 2001;298 (1):209-218.
5. Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol 2008;15(3):319-328.
6. Leaker BR, O'Connor B, Hansel TT, et al. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol 2008;15(3): 329-336.
7. Ananthasubramaniam K, Weiss R, Klauke B, McNutt B, Feaheny K. A multicenter, double-blind, randomized, placebo-controlled study of the safety and tolerance of regadenoson in patients with renal impairment. J Am Coll Cardiol 2011;57(14 suppl):E650.
8. Druz RS. Current advances in vasodilator pharmacological stress perfusion imaging. Semin Nucl Med 2009;39(3):204-209.
9. Thomas GS, Prill NV, Majmundar H, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol 2000;7(5): 439-446.
10. Jamil G, Ahlberg AW, Elliott MD, et al. Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single-photon emission computed tomographic myo-cardial perfusion imaging in coronary artery disease. Am J Cardiol 1999;84(4):400-403.
11. Elliot MD, Holly TA, Leonard SM, Hendel RC. Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging. J Nucl Cardiol 2000; 7(6):584-589.
12. Holly TA, Satran A, Bromet DS, et al. The impact of adjunctive adenosine infusion during exercise myocar-dial perfusion imaging: results of the Both Exercise and Adenosine Stress Test (BEAST) trial. J Nucl Cardiol 2003;10(3):291-296.
13. DePuey EG. Single-photon emission computed tomography artifacts. In: Zaret BL, Beller GA, eds. Clinical nuclear cardiology: state of the art and future directions. 3rd ed. Philadelphia, Pa: Mosby, 2005;82.
14. Corbett JR, Ficaro E P. Clinical review of attenuation-corrected cardiac SPECT. J Nucl Cardiol 1999;6 (1 pt 1):54-68.
15. Pazhenkottil AP, Ghadri JR, Nkoulou RN, et al. Improved outcome prediction by SPECT myocardial per-fusion imaging after CT attenuation correction. J Nucl Med 2011;52(2):196-200.
16. Hansen CL, Goldstein RA, Berman DS, et al. Myo-cardial perfusion and function single photon emission computed tomography. J Nucl Cardiol 2006;13(6): e97-e120.
17. Masood Y, Liu YH, Depuey G, et al. Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation. J Nucl Cardiol 2005;12(6):676-686.
18. Burrell S, MacDonald A. Artifacts and pitfalls in myo-cardial perfusion imaging. J Nucl Med Technol 2006; 34(4):193-211.
19. Nishina H, Slomka PJ, Abidov A, et al. Combined supine and prone quantitative myocardial perfusion SPECT: method development and clinical validation in patients with no known coronary artery disease. J Nucl Med 2006;47(1):51-58.
20. Slomka PJ, Nishina H, Abidov A, et al. Combined quantitative supine-prone myocardial perfusion SPECT improves detection of coronary artery disease and normalcy rates in women. J Nucl Cardiol 2007;14 (1):44-52.
21. Vitola JV, Brambatti JC, Caligaris F, et al. Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to-liver activity ratio on Tc-99m sestamibi imaging. J Nucl Cardiol 2001;8(6):652-659.
22. DePuey EG. Image artifacts. In: Iskandrian AE, Ve-rani MS, eds. Nuclear cardiac imaging: principles and applications. 3rd ed. New York, NY: Oxford University Press, 2003; 92.
23. Goetze S, Brown TL, Lavely WC, Zhang Z, Bengel FM. Attenuation correction in myocardial perfusion SPECT/CT: effects of misregistration and value of re-registration. J Nucl Med 2007;48(7):1090-1095.
24. Kennedy JA, Israel O, Frenkel A. Directions and magnitudes of misregistration of CT attenuation-corrected myocardial perfusion studies: incidence, impact on image quality, and guidance for reregistration. J Nucl Med 2009;50(9):1471-1478.
25. Higgins JP, Williams G, Nagel JS, Higgins JA. Left bundle-branch block artifact on single photon emission computed tomography with technetium Tc 99m (Tc-99m) agents: mechanisms and a method to decrease false-positive interpretations. Am Heart J 2006;152(4): 619-626.
26. Anagnostopoulos C, Harbinson M, Kelion A, et al. Procedure guidelines for radionuclide myocardial per-fusion imaging. Heart 2004;90(suppl 1):i1-i10.